A functional model for progestogen-induced breakthrough bleeding

Human Reproduction

Volumn 15, Issue , 2000, Pages 1-6

  Hickey, M ^a   Fraser, I S ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breakthrough bleeding; Endometrium; Microvasculature; Progestogens

Indexed keywords

ALPHA TOCOPHEROL; ANGIOGENIC FACTOR; ANGIOGENIN; CYTOKINE; ESTROGEN; FIBROBLAST GROWTH FACTOR; FLAVONOID; GESTAGEN; LEVONORGESTREL; MATRIX METALLOPROTEINASE; PROGESTERONE RECEPTOR; SEX HORMONE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; BREAKTHROUGH BLEEDING; CAPILLARY RESISTANCE; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG MECHANISM; ENDOMETRIUM; ENDOTHELIUM CELL; HEMOSTASIS; HUMAN; MENSTRUATION; MICROVASCULATURE; MODEL; TISSUE OXYGENATION;

EID: 0033824180     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.suppl_3.1     Document Type: Article

References (46)

1. Prolonged hypoxia alters endothelial barrier function
2. Menstruation
3. Task Force on Long-Acting Systemic Agents for Fertility Regulation. The associated between vaginal bleeding patterns and reasons for discontinuation of contraceptive use
4. Immunohistochemical characterization of stromal leukocytes in nonpregnant human endometrium
5. Granulated lymphocytes in human endometrium: Histochemical and immunohistochemical studies
6. Endometrial lymphomyeloid cells in abnormal uterine bleeding due to levonorgestrel (Norplant)
7. Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle
8. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system
9. Monitoring of hormone replacement therapy in postmenopausal women by transvaginal sonography and color flow doppler: Study in different phases of sequential therapy
10. Endometrial blood flow measured by xenon-133 clearance in women with normal menstrual cycles and dysfunctional uterine bleeding
11. A double-blind placebo-controlled trial of a new veno-active flavonoid fraction (S 5682) in the treatment of symptomatic capillary fragility
12. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel
13. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation
14. The structure of endometrial microvessels
15. The endometrial vascular appearance in Norplant users: Preliminary results from an hysteroscopic study
16. Precise measurements in intrauterine vascular structures at hysteroscopy in menorrhagia and during Norplant use
17. Changes in endometrial vascular density in Norplant users
18. Changes in endothelial cell basement membrane in Norplant users
19. The measurement of endometrial perfusion in Norplant users: A pilot study
20. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding
21. A morphometric study of the effects of oral norethisterone and levonorestrel and endometrial blood vessels
22. The morphological response of blood vessels of the endometrium to low dose oral norethisterone and levonorestrel
23. Endometrial morphology during the normal cycle and under the influence of contraceptive steroids
24. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy
25. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users
26. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium
27. The expression of interstitial collagenase in human endometrium is controlled by progesterone and by oestradiol and is related to menstruation
28. Menstruation in intraocular endometrial transplants in the rhesus monkey. Carnegie Institute of Washington. Publication No. 518
29. Immunolocalization of endothelin and neutral endopeptidase in the endometrium of users of subdermally implanted levonorgestrel (Norplant)
30. Basement membrane proteins: Molecular structure and function
31. Hormonal contraception and bleeding disturbances: A clinical overview
32. Immunohistochemical study of endometrial microvascular basement membrane components in women using Norplant
33. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium
34. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans
35. Endothelial cell dysfunction following prolonged activation progesterone receptor
36. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel
37. Perivascular smooth muscle α-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding
38. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant-2 contraception
39. Endometrial endothelin: Regulator of uterine bleeding and endometrial repair
40. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel
41. Angiogenesis
42. The effect of high dose medium and long-term progestogen exposure on endometrial vessels
43. Effect of high-dose progestogens on white cells and necrosis in human endometrium
44. Oxidative stress, vitamin E and progestin breakthrough bleeding
45. Endometrial breakdown in women using Norplant is associated with migratory cells expressing matrix metalloproteinase-9
46. Cytokeratins 8, 18 and 19 in endometrial epithelial cells during the normal menstrual cycle and in women receiving Norplant